Analystreport

Cidara Therapeutics Inc (NASDAQ: CDTX) had its price target lowered by analysts at Wedbush from $12.00 to $7.00. They now have an "outperform" rating on the stock.

Cidara Therapeutics, Inc.  (CDTX) 
Last cidara therapeutics, inc. earnings: 3/4 05:55 am Check Earnings Report
US:NASDAQ Investor Relations: ir.cidara.com